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ABSTRACT:  The  objective  of  our  research  project  was  screening  of  various  highly 
specific  substrates  of  Acetoxy  Drug:  Protein  Transacytylase  (M.TAase)  for 
antimycobacterial activity. Mycobacterial culture was done in Middlebrook’s 7H9 media. 
Protein purification (Mycobacterial Tranacetylase, M.TAase) was done by ion exchange 
chromatography  and  its  demonstration  was  done  on  SDS-  polyacrylamide  gel 
electrophoresis (SDS-PAGE) and western blot. Middlebrook’s 7H9 broth was procured 
from  Becton  Dickinson.  CM-Sepharose,  DEAE-Sepharose  and  Q-Sephharose  were 
purchased  from  Amersham  Pharmacia.  Anti  acetyl  lysine  polyclonal  antibody  was 
purchased from Cell Signaling. The Middlebrook 7H9 medium was used for M. smegmatis 
culture. The media was prepared according to the manufacturer’s instructions. The various 
Polyphenol acetate compounds were tested for their antimycobacterial activities. Minimal 
inhibitory concentrations (MIC) were calculated by Alamar blue dye assay method. The 
GST  protein  was  used  as  a  receptor  protein  and  purified  Mycobacterial  Glutamine 
Synthetase (GS) as TAase for acetylation by DAMC. To demonstrate the TAase catalyzed 
acetylation of GST by DAMC, purified M.TAase (GS) was preincubated with GST and 
DAMC followed by western blot using anti acetyl lysine antibody, which avidly react with 
the acetylated proteins. The growth pattern of M. smegmatis was diminished under the 
influence of various polyphenolic acetates (PA) tested for their anti-mycobacterial activity. 
DAMC  and  DAMC-5-carboxylic  acid  was  found  to  have  MIC  of  40µg/ml  whereas 
DAMC-6-carboxylic acid was reported to have MIC value of 35µg/ml and for ellagic acid 
tetra acetate (EATA) it was 60µg/ml. Previous work in our lab has led to discovery of a 
novel enzyme acetoxy drug: protein transacetylase (TAase), catalyzing transfer of acetyl 
group  from  various  polyphenolic  peracetate  (PA)  to  certain  receptor  proteins  such  as 
cytochromes P-450, NADPH cytochrome reductase, nitric oxide synthase (NOS) has been 
established  in  various  eukaryotic  as  well  as  prokaryotic    sources.  PA(s)  irreversible 
inhibitors of mammalian CYP linked MFO, possibly due to modification of cytochrome p-
450 by acetylation in a reaction catalysed by M.TAase (GS) utilizing PA(s) as a donor of 
acetyl groups. Accordingly, it was hypothesized that the CYP51 of mycobacteria involved 
in the cell wall sterol synthesis could possibly be modified by our PA(s) through the novel 
unknown action of GS as transacetylase leading to the death of mycobacterial cell by way 
of acetylation catalyzed by acetoxy drug: protein transacetylase (M.TAase or GS). 
 
KEY  WORDS:  Transacetylase;  Glutamine  synthetase;  Mycobacterium  smegmatis; 
Polyphenolic acetates; Acetoxy drug: protein transacetylase 
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INTRODUCTION 
 
Mycobacterium  tuberculosis  causes  more  human 
death  than  any  other  single  infectious  organism. 
According to the WHO global Tuberculosis report 
2011,  there  were  8.8  million  (range,  8.5–9.2 
million) incident cases of TB, 1.1 million (range, 
0.9–1.2  million)  deaths  from  TB  among  HIV-
negative  people  and  an  additional  0.35  million 
(range,  0.32–0.39  million)  deaths  from  HIV-
associated TB.
1 The prevalence of tuberculosis in 
India  is  3100,000  and  the  mortality  due  to  this 
deadly disease is 320,000.
1 
An apparent synergy between the epidemiology of 
AIDS and tuberculosis, with the HIV pandemic has 
intensified the growing problem in TB control. 
Current anti-tubercular drug regimens are lengthy, 
usually  lasting  up  to  6  months  and  includes  3-4 
components resulting in patient`s poor compliance 
is  one  of  the  major  factor  causing  multi-drug 
resistance  TB.  Due  to  multi-drug  resistance, 
treatment of TB is entering a new challenging era 
where effective control requires the identification 
of new drugs and novel therapeutic targets. 
Recently polyphenol acetate compounds have been 
a  growing  area  of  research  to  develop  novel 
therapeutic agents to combat the emergence of drug 
resistance tuberculosis. 
In our lab, a novel enzyme Acetoxcy Drug: Protein 
Transacetylase  (TAase),  catalyzing  transfer  of 
acetyl group from various polyphenolic peracetate 
(PA)  to  certain  receptor  proteins  such  as 
cytochromes  P-450,  NADPH  cytochrome 
reductase,  nitric  oxide  synthase  (NOS)  has  been 
established. Recently, TAase has been purified to 
homogeneity from rat liver and human placenta
2,3. 
The  N-terminal  amino  acid  sequence  analysis  of 
TAase  when  aligned  with  nonredundant  Swiss  -
Prot Database, sequence revealed a perfect match 
with N-terminal sequence of mature Calreticulin, a 
prominent  Ca2+  binding  protein  of  endoplasmic 
reticulum
4.  Further  studies  confirmed  the  identity 
of  TAase  as  Calreticulin  Transacetylase 
(CRTAase)
3. 
Again,  studies  were  undertaken  in  our  lab  to 
examine  the  existence  of  TAase  in  prokaryotic 
organism  i.e.  M.  smegmatis.  The  N-terminal 
sequence  of  purified  TAase  from  M.  smegmatis 
was  found  identical  with  Glutamine  Synthetase 
(GS)
5. Since nothing was known whether GS of M. 
smegmatis has TAase activity. 
The  objective  of  our  research  project  was   
screening  of  various  highly  specific  substrates  of 
TAse for antimycobacterial Acitivity. 
 
METHODOLOGY 
 
The study was conducted jointly in Department of 
Biochemistry, VP Chest Institute and Department 
of Chemistry, University of Delhi, India. 
Mycobacterial culture was done in Middlebrook’s 
7H9  media.  Protein  purification  (Mycobacterial 
Tranacetylase,  M.  TAase)  was  done  by  ion 
exchange  chromatography  and  its  demonstration 
was  done  on  SDS-polyacrylamide  gel 
electrophoresis (SDS-PAGE) and western blot. 
Middlebrook’s  7H9  broth  was  procured  from 
Becton  Dickinson.  CM-Sepharose,  DEAE-
Sepharose and Q-Sephharose were purchased from 
Amersham  Pharmacia.  Anti  acetyl  lysine 
Polyclonal  antibody  was  purchased  from  Cell 
Signaling. 
Acrylamide,  Bis-acryl  amide,  Ammonium  per 
sulphate and TEMED was purchased from BioRad. 
7,8-Diacetoxy-4-methylcoumarin  (DAMC),  7,8-
dihydroxy-4-methylcoumarin  (DHMC),  and 
various acetoxy ployphenols were kindly provided 
by  Chemistry  Department,  University  of  Delhi. 
Glycine,  Trizma  base,  Sodium  Dodecyl  Sulphate 
(SDS), Reduced Glutathione (GSH), 1-chlor-2, 4- 
dinitrobenzene  (CDNB),  were  procured  from 
Sigma Chemicals Co., St. Louis, Mo (USA).  Iodo 
acetamide was product of Lancaster Synthesis. All 
other chemicals and reagents were high purity and 
were obtained from local suppliers. 
 
The Bacterial Culture 
 
Preparation of the media 
 
The  Middlebrook  7H9  medium  was  used  for  M. 
smegmatis  culture.    The  media  was  prepared 
according to the manufacturer’s instructions. 
 
Inoculation 
 
The  liquid  media  was  taken  in  autoclaved-
stoppered glass tubes, not more than 1/3rd of the 
whole volume.  The inoculation was done near the 
flame under a laminar flow hood. After inoculation, 
the tubes were left at 37°C for three days of days in 
incubator room where temperature is maintained at 
37°C.  The mycobacterium thus obtained was used 
for further studies. 
 
Preparation of Cell Free Extract 
 
Cell  free  extract  was  prepared  by  a  standard 
method.  0.1  M  sodium  phosphate  (pH.  7.4)  was 
used for the preparation of cell free extracts.  The 
culture  was  taken  in  centrifuge  tubes  and 
centrifuged in the Sorvall centrifuge at 6000g for 
30 Min at 4°C.   The supernatant was discarded and 
the  cell  pellets  were  washed  and  dissolved  in 
minimum  amount  of  sonication  buffer  (0.1  M 
NaH2PO4;  pH  7.4)  containing  PMSF  and  DTT, 
and  collected  in  a  beaker.    Cold  sonication  was 
done in Misonix Sonicator; 16 pulses given at an 
interval of 1 min each.  The sonicated extract was 
centrifuged at 10,000g for 35 minutes in centrifuge Santram et al / Polyphenolic acetates: a newer anti-Mycobacterial therapeutic option 
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(Sorvall), for obtaining the cell free extracts.  The 
supernatant was taken and the pellet containing the 
cell  debris  was  discarded.    The  supernatant  thus 
obtained was centrifuged at 42,000rpm for 2.30hr. 
in ultracentrifuge (Beckman).  The pellet was kept 
for  further  use.  The  pellet  was  dissolved  in 
minimum amount of 0.1 M NaH2PO4, according to 
the pellet obtained. The sample was stored at 20°C. 
 
Demonstration  of  Mycobacterial  GS  catalyzed 
protein acetylation by DAMC using anti acetyl 
lysine antibodies 
 
The acetylation or acetylated lysine residues were 
detected  by  using  Anti  acetyl  lysine  Polyclonal 
antibody.  Purified GS (50 µg) was incubated with 
GST  as  a  receptor  protein,  DAMC  (100µM)  and 
0.25  potassium  phosphate  buffer  (pH6.5)  and 
incubated  for  30  minutes  at  37⁰C  in  water  bath.  
After  the  completion  of  reaction,  sample  buffer 
(loading dye) was added to the reaction mixture to 
stop the reaction. This reaction mixture was used to 
detect the acetylated protein using western blot. 
For  western  blot,  electrophoretically  separated 
proteins were transferred onto nitrocellulose sheets 
at 300mA for 3hrs at 4°C.  Non-specific sites on 
the nitrocellulose sheet were blocked with blocking 
reagent. Primary antibody dilution was prepared in 
TBST  containing  1%  BSA  and  incubation  was 
carried  out  at  4°C  for  12hrs  with  shaking  at 
intervals.    The  nitrocellulose  sheets  were 
extensively washed with TBST (TBS with 0.05% 
Tween).  Goat  anti-rabbit-HRP  (horseradish 
peroxidase)  conjugated  secondary  antibody 
(Bangalore Genie), appropriately diluted in TBST 
was then added and an incubation of 1hr at room 
temperature  was  carried  out.  The  sheets  were 
washed extensively and antibody-reactive moieties 
were  visualized  with  DAB  (Diaminobenzidine) 
system  (Bangalore  Genie).  After  5  minutes 
incubation reagents were drained, and sheets were 
kept in water. 
 
Screening  of  various  polyphenolic  acetates 
against Mycobacterium smegmatis 
 
Several  compounds  synthesized  in  our  laboratory 
were  tested  for  their  antimycobacterial  activity.  
The  compounds  were  tested  against 
Mycobacterium  smegmatis.  The  mycobacterium 
was  grown  in  Middle  brook's  7H9  media, 
depending on the growth conditions of the bacteria, 
which gave an optimum growth of the test bacteria.  
Cell suspensions were prepared and diluted in 7H9 
Middlebrook's liquid broth so that their turbidities 
matched that of McFarland no.1 turbidity standard
6. 
Each  compound  was  dissolved  in  Dimethyl 
sulphoxide (DMSO 10mg/ml) sterilized by filtering 
through  membrane  filters  (0.25  µm).  Stock 
solutions were diluted in 7H9 broth to two times 
the  maximum  desired  final  testing  concentrations 
prior  to  their  addition  to  micro  plates.    200µl  of 
sterile  deionized  water  was  added  to  all  outer 
perimeter wells of sterile 96-well (round bottom) 
plates  (Tarsons)  to  minimize  evaporation  of  the 
medium in the test wells during incubation.  The 
wells in rows B to G in columns 3 to 11 received 
100µl of 7H9 Middlebrook's broth.  100µl of 2X 
drug solutions were added to the wells in rows B to 
G columns 2 and 3.  By using an autopipette, 100µl 
was  transferred  from  column  3  to  4  and  the 
contents of the wells were mixed well.  Identical 
serial 1:2 dilutions were continued through column 
10,  and  100µl  of  excess  medium  was  discarded 
from  the  wells  in  column10.  Final  drug 
concentration ranges were 10 to 100µg/ml.  100µl 
of M. smegmatis inoculum was added to the wells 
in rows B to G in columns 2 to 11. Thus the wells 
in column 11 served as drug free (inoculum only) 
controls. The plates were sealed with Parafilm and 
were incubated at 37°C for 72 hrs.  Fifty microliters 
of a freshly prepared 1:1 mixture of 10X Alamar 
Blue reagent and 10% Tween 80 was added to all 
the  wells.  Color  changes  were  recorded  visually 
after 24 hrs. Blue color denotes no growth whereas 
pink color shows growth
7. 
 
RESULT 
 
Demonstration of TAase catalyzed acetylation of 
proteins by DAMC 
 
The GST protein was used as a receptor protein and 
Mycobacterial  GS  as  TAase  for  acetylation  by 
DAMC.  To  demonstrate  the  TAase  catalyzed 
acetylation of GST by DAMC, purified TAase was 
preincubated  with  GST  and  DAMC  followed  by 
western  blot  using  anti  acetyl  lysine  antibody, 
which  avidly  react  with  the  acetylated  proteins. 
Figure  1  shows  TAase  catalyzed  acetylation  of 
Glutathione-S-transferase by DAMC. 
 
Figure  1:  GS  (MTase)  catalysed  acetylation  of 
GST by PA (DAMC) 
Western  blot  analysis  using  anti-acetyl  lysine 
polyclonal antibodies 
Lane  1  Protein  markers;  Lane  2  GST+DMSO; 
Lane 3 GST + GS + DAMC; Lane 4 GST +DAMC	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Growth inhibition of Mycobacterium smegmatis 
under the influence of various PA 
 
The  growth  pattern  of  M.  smegmatis  was 
diminished  under  the  influence  of  various  PA 
tested for their anti-mycobacterial activity. DAMC 
and  DAMC-5-carboxylic  acid  was  found  to  have 
MIC of 40µg/ml whereas DAMC-6-carboxylic acid 
was reported to have MIC value of 35µg/ml and for 
ellagic acid tetra acetate (EATA) it was 60µg/ml 
(Figure 2). 
 
 
Figure  2:  MIC  determination:  various  PA(s) 
examined for antimycobacterial activity 
 
DISCUSSION 
 
The  role  of  protein  modification  in  control  of 
cellular  processes  is  well  known.  Among  protein 
modification, the acetylation of protein assumes the 
crucial role in cellular metabolism. The acetylation 
of  protein  is  catalyzed  by  Acetyl  CoA-specific 
acetyl  transferases.  The  importance  of  histone 
acetyl transferases, p53 specific acetyl transferase 
etc.  are  some  of  the  well  known  examples  of 
enzymatic protein acetylation involving Acetyl Co 
A as the acetyl group donor.  
The earlier work carried out in our laboratory on 
the  biochemical  action  of  polyphenolic  acetates, 
PA(s)  focused  our  attention  on  the  role  of 
enzymatic  acetylation  of  protein  independent  of 
Acetyl CoA
8. PA(s) were found to acetylate certain 
proteins  mediated  by  an  enzyme  localized  in  rat 
liver  microsomes.  Since,  a  large  number  of 
polyphenolic acetates were found to be substrates, 
the  aforementioned  enzyme  was  named  Acetoxy 
drug:  protein  Transacetylase  (TAase).  An  assay 
procedure for TAase was developed based on the 
irreversible inhibition of Glutathione-S-transferase 
(GST) by PA, the extent of inhibition of GST was 
considered proportional to the activity of TAase. 
Using this assay procedure, TAase was purified to 
homogeneity from buffalo liver
9, rat liver
2, human 
placenta  and  buffalo  lung.  Then  the  efforts  were 
made to examine the possible existence of TAase in 
prokaryotic  organisms  and  Mycobacterium 
smegmatis was the chosen organism. Considerable 
TAase activity was found in the cell free extract of 
M. smegmatis. 
In-depth  studies  were  conducted  to  decipher  the 
protein identity of M. TAase . For this purpose, the 
N-terminal sequencing of purified M. TAase was 
carried out. Further, the N-terminal sequence of M. 
TAase  when  aligned  with  non-redundant  Swiss 
Prot  database  revealed  100%  identity  with  N-
terminal sequence of Glutamine Synthetase (GS) of 
M. smegmatis. 
The present study was carried out to screen various 
polyphenol  acetates  (PA)  for  their 
antimycobacterial  activity.  GS  catalyzed  protein 
acetylation was further confirmed by demonstration 
of acetylation of a Receptor proteins such as GST 
when incubated with DAMC at 37°C followed by 
Western  blot  using  anti-acetyl-lysine  antibody 
which  avidly  react  with  acetylated  receptor  GST 
protein (Figure 1). Thus, we concluded that TAase 
activity is a novel, unknown function of GS. 
The  observation  of  various  investigations 
highlighted  CYP51  linked  MFO  as  the  crucial 
enzyme involved in sterol biosynthesis and could 
serve  as  a  suitable  target  for  the  development  of 
drug  candidates
10.  Sterol  14α-demethylase  of  M. 
tuberculosis was found to be CYP51 linked MFO. 
Several well-known azoles, which were known to 
be the inhibitors of fungal CYP linked MFO, were 
considered  as  suitable  drugs  to  target  strol  14  α-
demethylase of M. tuberculosis
11. The earlier work 
carried  out  in  our  laboratory  projected  PA(s)  as 
irreversible  inhibitors  of  mammalian  CYP  linked 
MFO,  possibly  due  to  modification  of  p-450  by 
way  of  acetylation  catalyzed  by  acetoxy  drug: 
protein Transacetylase
12-14. 
Accordingly, it was hypothesized that the CYP51 
of  mycobacteria  involved  in  the  cell  wall  sterol 
synthesis could possibly be modified by our PA(s) 
through  the  novel  unknown  action  of  GS  as 
transacetylase leading to the death of mycobacterial 
cells.  The  result  of  the  various  investigations 
conducted  in  our  lab  substantiated  the  TAase 
activity of the purified GS of M. smegmatis. Hence, 
it was thought pertinent to examine whether TAase 
of mycobacteria utilizing PA(s) as a donor of acetyl 
group  could  be  culminating  in  the  acetylation  of 
mycobacterial CYPs.  
Such  an  approach  was  thought  novel  and 
innovative  to  examine  the  anti  mycobacterial 
effects of PA. We then set forth to screen, in the 
first  instance,  to  examine  several  acetoxy 
coumarins for their ability to inhibit the growth of 
M. smegmatis. The DAMC-6-carboxylic acid gave 
a  surprisingly  low  MIC  value  of  35µg/ml  in 
comparison to the 40µg/ml given by DAMC. The 
order  in  which  the  PA  were  effective  against 
mycobacterial  growth  can  be  evaluated  as  7,8-
DAMC-6-carboxylic  acid>7,8-DAMC>7,8-
DAMC-5-carboxylic acid >EATA (Figure 2).  
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CONCLUSION 
 
To  conclude  from  our  research  project,  purified 
mycobacterial  GS  exhibited  Protein: 
acetyltransferase  (TAase)  activity.  The  TAase 
activity of Mycobacterial GS was found useful to 
target  certain  receptor  protein  by  PA  in 
Mycobacteria.  PA(s)  were  effective  against 
mycobacterial growth in the following order: 7,8-
DAMC-6-carboxylic  acid>7,8-DAMC>7,8-
DAMC-5-carboxylic  acid>EATA.  The  action  of 
PA(s) could possibly be utilized in the development 
of effective anti-TB drugs in future. 
Further study with more number of acetoxy drugs 
and  their  antimycobacterial  effect  on  human 
tuberculosis (M. tuberculosis, M. bovis) is needed. 
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